http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2015201253-A1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_dcce39a20bef16c3f04497659caba40f |
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-24 |
filingDate | 2015-03-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f2a42752a89cd882af7b55fd316cdd6f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e69b8151e848cc2791ee6fcf940d4ccc http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c324cce01c91373a452dc4d9552d2550 |
publicationDate | 2015-04-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | AU-2015201253-A1 |
titleOfInvention | Antibodies that bind to IL-18 and methods of purifying the same |
abstract | ANTIBODIES THAT BIND TO IL-18 AND METHODS OF PURIFYING THE Anti-IL- 18 antibodies are disclosed herein, including antigen-binding 5 portions thereof. One or more methods for isolating and purifying anti-IL-18 antibodies from a sample matrix is presented. These isolated anti-IL-18 antibodies can be used in a clinical setting as well as in research and development. Pharmaceutical compositions comprising isolated anti-IL-18 antibodies are also described. |
priorityDate | 2008-10-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 617.